| 1 |
潘灏, 杨学军, 李志勇, 等. 2021年世界卫生组织中枢神经系统肿瘤分类(第五版)室管膜肿瘤分类解读 [J]. 中国现代神经疾病杂志, 2021, 21(9): 809-816.
|
| 2 |
Fan F, Zhou J, Zheng Y, et al. Clinical features, treatments, and prognostic factors of spinal myxopapillary ependymoma [J]. World Neurosurg, 2021, 149: e1105-e1111.
|
| 3 |
Helbig D. Subcutaneous sacral ependymoma-a histopathological challenge [J]. J Cutan Pathol, 2016, 43(1): 71-74.
|
| 4 |
Bruno F, Pellerino A, Bertero L, et al. Long-term survival of a sacro-coccygeal myxopapillary ependymoma with extra-neural metastases: case report and review of the literature [J]. Neurol Sci, 2020, 41(7): 1955-1957.
|
| 5 |
Shelekhova KV, Egorenkov VV, Kheinstein VA, et al. Myxopapillary ependymoma of lumbar soft tissue: A case report with gene expression evaluation [J]. Int J Surg Pathol, 2018, 26(4): 364-369.
|
| 6 |
Yust Katz S, Cachia D, Kamiya-Matsuoka C, et al. Ependymomas arising outside of the central nervous system: A case series and literature review [J]. J Clin Neurosci, 2018, 47: 202-207.
|
| 7 |
Ilhan A, Furtner J, Birner P, et al. Myxopapillary ependymoma with pleuropulmonary metastases and high plasma glial fibrillary acidic protein levels [J]. J Clin Oncol, 2011, 20, 29(30): e756-e757.
|
| 8 |
Fegerl G, Marosi C. Stabilization of metastatic myxopapillary ependymoma with sorafenib [J]. Rare Tumors, 2012, 4(3): e42.
|
| 9 |
Sonneland PR, Scheithauer BW, Onofrio BM. Myxopapillary ependymoma. A clinicopathologic and immunocytochemical study of 77 cases [J]. Cancer, 1985, 56(4): 883-893.
|
| 10 |
Helwig EB, Stern JB. Subcutaneous sacrococcygeal myxopapillary ependymoma. A clinicopathologic study of 32 cases [J]. Am J Clin Pathol, 1984, 81(2): 156-161.
|
| 11 |
Kelly A, Nally D, Crowther S, et al. Subcutaneous sacrococcygeal myxopapillary ependymoma misdiagnosed as pilonidal disease [J]. BMJ Case Rep, 2020, 13(1): e231639.
|
| 12 |
Limaiem F, Das JM. Myxopapillary ependymoma. 2023 Jan 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-PMID: 32644598
|
| 13 |
Thejeel B, Rajakulasingam R, Balogh P, et al. Diagnosis: subcutaneous myxopapillary ependymoma [J]. Skeletal Radiol, 2020, 49(7): 1159-1160.
|
| 14 |
Levine AB, Wong D, Fatehi M, et al. Ependymoma and chordoma [J]. Neurosurgery, 2020, 87(5): 860-870.
|
| 15 |
Schiavello E, Biassoni V, Antonelli M, et al. Pediatric extraspinal sacrococcygeal ependymoma (ESE): an Italian AIEOP experience of six cases and literature review [J]. Childs Nerv Syst, 2018, 34(7): 1291-1298.
|
| 16 |
Saleh AH, Samuel N, Juraschka K, et al. The biology of ependymomas and emerging novel therapies [J]. Nat Rev Cancer, 2022, 22(4): 208-222.
|
| 17 |
Tang X, Guo W, Yang R, et al. Risk factors for blood loss during sacral tumor resection [J]. Clin Orthop Relat Res, 2009, 467(6): 1599-1604.
|
| 18 |
陈文华, 王祁, 何忠明, 等. 术前肿瘤动脉栓塞联合术中腹主动脉球囊阻断在骶骨肿瘤切除术中的应用 [J]. 介入放射学杂志, 2012, 21(3): 212-215.
|
| 19 |
李海伟, 刘静. 骶尾部脊索瘤切除术前靶血管栓塞与术中球囊阻断腹主动脉的疗效比较[J]. 中国医科大学学报, 2014, (5): 454-457.
|
| 20 |
胡璐璐, 许雅娟, 翟闪闪, 等. 腹主动脉球囊阻断术用于凶险性前置胎盘合并胎盘植入剖宫产术的并发症及处理 [J]. 现代妇产科进展, 2020, 29(7): 527-530.
|
| 21 |
Batich KA, Riedel RF, Kirkpatrick JP, et al. Recurrent extradural myxopapillary ependymoma with oligometastatic spread [J]. Front Oncol, 2019, 9: 1322.
|
| 22 |
Bobola MS, Jankowski PP, Gross ME, et al. Apurinic/apyrimidinic endonuclease is inversely associated with response to radiotherapy in pediatric ependymoma [J]. Int J Cancer, 2011, 129(10): 2370-2379.
|
| 23 |
van Vuurden DG, Hulleman E, Meijer OL, et al. PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation [J]. Oncotarget, 2011, 2(12): 984-996.
|
| 24 |
Rudà R, Reifenberger G, Frappaz D, et al. EANO guidelines for the diagnosis and treatment of ependymal tumors [J]. Neuro Oncol, 2018, 20(4): 445-456.
|
| 25 |
Fujiwara Y, Manabe H, Izumi B, et al. Remarkable efficacy of temozolomide for relapsed spinal myxopapillary ependymoma with multiple recurrence and cerebrospinal dissemination: a case report and literature review [J]. Eur Spine J, 2018, 27(Suppl 3): 421-425.
|
| 26 |
Adolph JE, Fleischhack G, Mikasch R, et al. Local and systemic therapy of recurrent ependymoma in children and adolescents: short- and long-term results of the E-HIT-REZ 2005 study [J]. Neuro Oncol, 2021, 23(6): 1012-1023.
|
| 27 |
Gururangan S, Fangusaro J, Young Poussaint T, et al. Lack of efficacy of bevacizumab+irinotecan in cases of pediatric recurrent ependymoma-a pediatric brain tumor consortium study [J]. Neuro Oncol, 2012, 14(11): 1404-1412.
|